• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

东莨菪碱作为认知障碍药理学模型的有效性:动物行为研究综述。

The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies.

机构信息

Faculty of Psychology and Neuroscience, EURON, Department of Neuropsychology and Psychopharmacology, Maastricht University, Maastricht, The Netherlands.

出版信息

Neurosci Biobehav Rev. 2010 Jul;34(8):1307-50. doi: 10.1016/j.neubiorev.2010.04.001. Epub 2010 Apr 14.

DOI:10.1016/j.neubiorev.2010.04.001
PMID:20398692
Abstract

Scopolamine is used as a standard/reference drug for inducing cognitive deficits in healthy humans and animals. Effects are often interpreted in terms of a role of acetylcholine in mnemonic and/or attentional processes. In this paper an overview is given of the effects of scopolamine on animal behavior. Examination of the dose-response curve of systemically administered scopolamine indicates that sensory discrimination and attention are most sensitive to disruption. When higher doses (>0.03mg/kg) are used, deficits in other cognitive and non-cognitive functions (e.g., learning and memory, locomotor activity) are reported. Several behavioral processes (taste aversion, anxiety, short-term memory, attention) are found to be affected after intracerebral injections of scopolamine. It is concluded that effects on learning and memory performance which are observed after higher doses of scopolamine are mediated by (1) primary effects on attention and sensory/stimulus discrimination, (2) non-specific effects on behavior (e.g., locomotor activity, anxiety), and (3) peripheral side-effects (e.g., pupil dilation, salivation). Finally, the validity of scopolamine as a pharmacological model for cognitive impairment is discussed. The use of muscarinic M1 antagonists is suggested as a more selective and effective way of inducing cholinergic-induced cognitive deficits.

摘要

莨菪碱被用作诱导健康人类和动物认知缺陷的标准/参考药物。其作用通常被解释为乙酰胆碱在记忆和/或注意力过程中的作用。本文概述了莨菪碱对动物行为的影响。检查系统给予的莨菪碱的剂量-反应曲线表明,感觉辨别和注意力最容易受到干扰。当使用更高剂量(>0.03mg/kg)时,报告了其他认知和非认知功能(例如,学习和记忆,运动活动)的缺陷。发现脑内注射莨菪碱后,几种行为过程(味觉厌恶,焦虑,短期记忆,注意力)受到影响。结论是,在更高剂量的莨菪碱后观察到的学习和记忆性能的影响是由(1)对注意力和感觉/刺激辨别有直接作用,(2)对行为有非特异性作用(例如,运动活动,焦虑),和(3)外周副作用(例如,瞳孔扩张,唾液分泌)介导的。最后,讨论了莨菪碱作为认知障碍的药理学模型的有效性。建议使用毒蕈碱 M1 拮抗剂作为诱导胆碱能引起的认知缺陷的更具选择性和有效的方法。

相似文献

1
The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies.东莨菪碱作为认知障碍药理学模型的有效性:动物行为研究综述。
Neurosci Biobehav Rev. 2010 Jul;34(8):1307-50. doi: 10.1016/j.neubiorev.2010.04.001. Epub 2010 Apr 14.
2
Scopolamine induced deficits in a battery of rat cognitive tests: comparisons of sensitivity and specificity.东莨菪碱在一系列大鼠认知测试中诱发的缺陷:敏感性和特异性的比较。
Behav Pharmacol. 2009 May;20(3):237-51. doi: 10.1097/FBP.0b013e32832c70f5.
3
Further evidence for the cholinergic hypothesis of aging and dementia from the canine model of aging.衰老和痴呆症胆碱能假说的进一步证据:来自犬类衰老模型的研究
Prog Neuropsychopharmacol Biol Psychiatry. 2005 Mar;29(3):411-22. doi: 10.1016/j.pnpbp.2004.12.008.
4
(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.(±)-顺式-2-甲基-螺(1,3-氧硫杂环戊烷-5,3')奎宁环,一种M1选择性胆碱能激动剂,可减轻阿尔茨海默病动物模型中的认知功能障碍。
J Pharmacol Exp Ther. 1991 Apr;257(1):392-403.
5
Effects of a memory enhancing peptide on cognitive abilities of brain-lesioned mice: additivity with huperzine A and relative potency to tacrine.一种记忆增强肽对脑损伤小鼠认知能力的影响:与石杉碱甲的相加作用及相对于他克林的效价
J Pept Sci. 2006 Jan;12(1):72-8. doi: 10.1002/psc.682.
6
Rats with scopolamine- or MK-801-induced spatial discrimination deficits in the cone field task: animal models for impaired spatial orientation performance.在锥体场任务中出现东莨菪碱或MK - 801诱导的空间辨别缺陷的大鼠:空间定向能力受损的动物模型。
Eur Neuropsychopharmacol. 2005 May;15(3):331-46. doi: 10.1016/j.euroneuro.2004.11.006. Epub 2005 Jan 26.
7
Effect of FR121196, a novel cognitive enhancer, on the memory impairment of rats in passive avoidance and radial arm maze tasks.新型认知增强剂FR121196对大鼠在被动回避和放射状臂迷宫任务中记忆损伤的影响。
J Pharmacol Exp Ther. 1992 Nov;263(2):436-44.
8
The use of effect sizes to characterize the nature of cognitive change in psychopharmacological studies: an example with scopolamine.在精神药理学研究中使用效应量来表征认知变化的本质:以东莨菪碱为例。
Hum Psychopharmacol. 2008 Jul;23(5):425-36. doi: 10.1002/hup.942.
9
Injections of tacrine and scopolamine into the nucleus accumbens: opposing effects of immediate vs delayed posttrial treatment on memory of an open field.向伏隔核注射他克林和东莨菪碱:试验后即刻与延迟治疗对旷场记忆的相反作用。
Neurobiol Learn Mem. 2000 Jan;73(1):21-30. doi: 10.1006/nlme.1999.3915.
10
Memantine prevents the cognitive impairment induced by 3,4-methylenedioxymethamphetamine in rats.美金刚可预防大鼠中由3,4-亚甲基二氧甲基苯丙胺引起的认知障碍。
Eur J Pharmacol. 2008 Jul 28;589(1-3):132-9. doi: 10.1016/j.ejphar.2008.05.014. Epub 2008 May 20.

引用本文的文献

1
Scopolamine-Induced Amnesia in Zebrafish: Behavioral Characterization and Pharmacological Reversal.东莨菪碱诱导斑马鱼失忆:行为特征及药理学逆转
Animals (Basel). 2025 Sep 8;15(17):2624. doi: 10.3390/ani15172624.
2
Neuroprotective Potential of Phytocompounds in the Treatment of Dementia: The State of Knowledge from the Scopolamine-Induced Animal Model of Alzheimer's Disease.植物化合物在痴呆治疗中的神经保护潜力:来自东莨菪碱诱导的阿尔茨海默病动物模型的研究现状
Curr Issues Mol Biol. 2025 Aug 8;47(8):635. doi: 10.3390/cimb47080635.
3
Distinctive Effects of Fullerene C and Fullerenol C(OH) Nanoparticles on Histological, Molecular and Behavioral Hallmarks of Alzheimer's Disease in APPswe/PS1E9 Mice.
富勒烯C和富勒醇C(OH)纳米颗粒对APPswe/PS1E9小鼠阿尔茨海默病组织学、分子和行为特征的独特影响。
Antioxidants (Basel). 2025 Jul 8;14(7):834. doi: 10.3390/antiox14070834.
4
Lead Optimization of a Butyrylcholinesterase Inhibitor for the Treatment of Alzheimer's Disease.用于治疗阿尔茨海默病的丁酰胆碱酯酶抑制剂的先导优化
J Med Chem. 2025 Jun 12;68(11):11693-11723. doi: 10.1021/acs.jmedchem.5c00577. Epub 2025 Jun 2.
5
Kaempferia parviflora extract and its methoxyflavones as potential anti-Alzheimer assessing in vitro, integrated computational approach, and in vivo impact on behaviour in scopolamine-induced amnesic mice.山柰提取物及其甲氧基黄酮作为潜在抗阿尔茨海默病药物的体外评估、综合计算方法以及对东莨菪碱诱导的记忆缺失小鼠行为的体内影响
PLoS One. 2025 Mar 10;20(3):e0316888. doi: 10.1371/journal.pone.0316888. eCollection 2025.
6
Muscarinic receptor agonists and positive allosteric modulators in animal models of psychosis: protocol for a systematic review and meta-analysis.毒蕈碱受体激动剂和正变构调节剂在精神病动物模型中的应用:系统评价与荟萃分析方案
F1000Res. 2025 Jan 2;13:1017. doi: 10.12688/f1000research.155356.2. eCollection 2024.
7
Dexmedetomidine Improves Learning Functions in Male Rats Modeling Cognitive Impairment by Modulating the BDNF/TrkB/CREB Signaling Pathway.右美托咪定通过调节BDNF/TrkB/CREB信号通路改善认知障碍模型雄性大鼠的学习功能。
Life (Basel). 2024 Dec 17;14(12):1672. doi: 10.3390/life14121672.
8
MorphoGlia, an interactive method to identify and map microglia morphologies, demonstrates differences in hippocampal subregions of an Alzheimer's disease mouse model.MorphoGlia是一种识别和绘制小胶质细胞形态的交互式方法,它揭示了阿尔茨海默病小鼠模型海马亚区的差异。
Front Cell Neurosci. 2024 Dec 3;18:1505048. doi: 10.3389/fncel.2024.1505048. eCollection 2024.
9
A comparison of cognitive decline in aged mice and mice treated with aftin-4.衰老小鼠与 aftin-4 处理小鼠认知能力下降的比较。
Sci Rep. 2024 Nov 16;14(1):28320. doi: 10.1038/s41598-024-79792-3.
10
Analysis of Differential microRNA Expression in the Hippocampus of Scopolamine-Induced Amnesic Mouse Model.东莨菪碱诱导的失忆小鼠模型海马中差异微小RNA表达的分析
Mol Neurobiol. 2025 Apr;62(4):4881-4898. doi: 10.1007/s12035-024-04573-y. Epub 2024 Nov 4.